As an innovator of transformative therapies and upper nasal drug delivery, we seek to harness our expertise in upper nasal cavity drug delivery, our understanding of pharmaceutical biodistribution and the unmet needs of patients struggling with central nervous system disorders. With a late-stage pipeline of proprietary CNS product candidates, we are open to partnerships with our existing programs and potential new pipeline candidates. Given Impel’s focus, partnerships are sought with parties that share our focus and expertise in CNS drug development and commercialization.

Partnership Icon